knowledge -WSS

knowledge

author：knowledge 2025-09-03 11:47:08 - browse：5

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

Four alarming medical procedures we’re glad history forgot

Oral obesity drug from Viking Therapeutics hits key early target

J&J reports mixed data on next

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Pharma’s losing bet in New Jersey

Louisiana bill approved classifying abortion pills as controlled substances

leisure time

knowledge

hotspot

Virginia high school admissions case could be legal follow

The Bio Revolution is changing business and society

Walensky prepares to leave CDC — and Congress — behind

Protect nursing home residents from future pandemics

Malaria cases in Florida and Texas: Here’s what you need to know

Lawsuit challenges CMS nursing home minimum staffing rule

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Oral obesity drug from Viking Therapeutics hits key early target

The high cost of giving birth even with insurance

Asahi Kasei to buy Calliditas, picking up kidney disease drug

leisure time

Should insurance cover cosmetic surgery?

Insurer loopholes limit power of law against surprise medical bills

The world needs the new pandemic treaty

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Bird flu makes raw milk dangerous to consume, mouse study finds

Louisiana bill approved classifying abortion pills as controlled substances

knowledge

focus

hotspot

leisure time